Loading…
CIK 0001616824 • 6 13F filings • May 7, 2025 – Aug 7, 2026
Import this data to Google Sheets with:
=jivedata("bml-capital-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS INC | COM | $20.2M | 15.3%Prev: 34.3% | 14,250,000 SH | Decreased |
| ADVERUM BIOTECHNOLOGIES INC | COM NEW | $6.6M | 5.0% | 3,057,526 SH | New |
| ALUMIS INC | COM | $3.6M | 2.7% | 1,210,415 SH | New |
| ASTROTECH CORP | COM | $1.3M | 1.0% | 220,410 SH | New |
| ATEA PHARMACEUTICALS INC | COM | $27.4M | 20.7%Prev: 24.4% | 7,609,812 SH | Decreased+551,155 SH |
| ATHIRA PHARMA INC | COM | $976K | 0.7% | 3,230,667 SH | New |
| CONNECT BIOPHARMA HLDGS LTD | ADS | $1.8M | 1.4% | 1,821,558 SH | New |
| CORVUS PHARMACEUTICALS INC | COM | $475K | 0.4% | 118,766 SH | New |
| ELEVATION ONCOLOGY INC | COM | $2.2M | 1.6% | 5,890,434 SH | New |
| ESSA PHARMA INC | COM NEW | $7.2M | 5.4% | 4,221,546 SH | New |
| HILLEVAX INC | COM | $183K | 0.1% | 91,913 SH | New |
| IKENA ONCOLOGY INC | COM | $5.4M | 4.1% | 4,030,102 SH | New |
| INSTIL BIO INC | COM NEW | $11.1M | 8.4%Prev: 3.4% | 534,899 SH | Increased-110,701 SH |
| KEZAR LIFE SCIENCES INC | COM NEW | $2.9M | 2.2%Prev: 3.4% | 635,183 SH | Decreased-85,604 SH |
| LAVA THERAPEUTICS NV | SHS | $2.6M | 2.0% | 1,970,610 SH | New |
| LISATA THERAPEUTICS INC | COM | $608K | 0.5% | 209,814 SH | New |
| MILESTONE PHARMACEUTICALS IN | COM | $2.2M | 1.7% | 1,136,091 SH | New |
| ORAMED PHARMACEUTICALS INC | COM NEW | $6.9M | 5.2%Prev: 6.9% | 3,083,253 SH | Decreased-83,978 SH |
| PMV PHARMACEUTICALS INC | COM | $5.3M | 4.0%Prev: 4.2% | 5,000,000 SH | Decreased-320,000 SH |
| TESLA INC | COM | $1.7M | 1.3% | 200 SH | New |
| THIRD HARMONIC BIO INC | COM | $20.8M | 15.7% | 3,824,417 SH | New |
| TURNSTONE BIOLOGICS CORP | COM | $396K | 0.3% | 1,103,386 SH | New |
| VERRICA PHARMACEUTICALS INC | COM | $93K | 0.1% | 174,651 SH | New |
| VISTAGEN THERAPEUTICS INC | COM | $300K | 0.2% | 150,000 SH | New |
| 13F-HR |
| 0001754960-26-000696 |
| $176.1M |
| View |
| Aug 11, 2025 | Q2 2025 | 13F-HR | 0001754960-25-000555 | $132.2M | View |
| May 6, 2026 | Q1 2026 | 13F-HR | 0001754960-26-000359 | $155.8M | View |
| May 7, 2025 | Q1 2025 | 13F-HR | 0001754960-25-000280 | $123.6M | View |